Most parents support childhood vaccines like MMR and polio, but skepticism about seasonal and newer shots persists along with distrust of federal agencies.
Merck's CAPVAXIVE could cover approximately 78% of invasive pneumococcal disease cases in youth with chronic health conditions, vs other approved pneumococcal conjugate vaccines.